Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer
Objective: Evaluate the incidence and characteristics of breast cancers (BC) diagnosed following an epithelial ovarian cancer (EOC) diagnosis in women with pathogenic BRCA mutations. Methods: Retrospective cohort study of all women in an integrated healthcare system with BRCA mutations diagnosed wit...
Saved in:
Main Authors: | Andrea Nañez (Author), Douglas A. Stram (Author), C. Bethan Powell (Author), Christine Garcia (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series
by: Koji Matsuo, et al.
Published: (2018) -
BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
by: Tarinee Manchana, et al.
Published: (2020) -
BRCA mutation in high grade epithelial ovarian cancers
by: Tarinee Manchana, et al.
Published: (2019) -
The Modern Approaches and Future Perspectives on Breast and Ovarian Cancer Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers: A Literature Overview
by: Sandra Sarnacka, et al.
Published: (2024) -
Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
by: Alan D McCrorie, et al.
Published: (2020)